Impact assessment

Fees for Pharmaceutical Services: Impact Assessment

This initiative introduced in 2008, through Directions to NHS Primary Care Trusts (PCTs), a charging regime for applicants applying to provide NHS pharmaceutical services as a contribution towards the costs the NHS incurs in dealing with such applications.

From:
Department of Health and Social Care
Published
24 July 2012
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Documents

Fees for Pharmaceutical Services: Impact Assessment

PDF, 120 KB, 13 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Fees for NHS Pharmaceutical Services: Equality Analysis

PDF, 83.8 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This IA (IA 5098) updates the previous 2008 impact assessment to take account of a review of that original initiative in 2009 and changes now being introduced to the main NHS (Pharmaceutical Services) Regulations from summer 2012 which govern entry to the NHS market.

Published 24 July 2012